Trials / Sponsors / SOTIO Biotech AG
SOTIO Biotech AG
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2024-05-01 |
| Terminated | A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Pat Colorectal Cancer | Phase 2 | 2022-12-22 |
| Terminated | A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selec Non-Small Cell Lung Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma | Phase 2 | 2022-06-21 |
| Terminated | Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumor Thyroid Cancer, Renal Cell Carcinoma, Non Small Cell Lung Cancer | Phase 1 | 2019-06-13 |